Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
A substudy within the Phase 2 trial also found that retatrutide reduced liver fat by up to 82% in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called fatty liver disease
Individuals often see the best outcomes when paired with lifestyle changes
For more information, please review our Privacy Policy.
One patient maintained 92% of her muscle mass while losing another 8 pounds of pure fat during months 8-11
US$ 27.60
US$ 28.28
.png)
US$ 27.66
US$ 26.12
/assets/images/provider/photos/2813769.png)
